CDH1 and cervical cancer: Immunohistochemical analysis showed that during the cervical cancer stage, HIV-positive patients exhibited significantly decreased levels of E-cadherin and cytokeratin, and increased levels of vimentin in cervical lesion tissues as compared to HIV-negative patients (all P < 0.05, Fig. 2).